Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Jefferies Sticks to Its Sell Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)

Tipranks - Tipranks - Tue Mar 3, 3:00AM CST

In a report released today, James Vane from Jefferies maintained a Sell rating on Fresenius Medical Care AG & Co. KGaA, with a price target of €32.00.

Claim 50% Off TipRanks Premium

Vane covers the Healthcare sector, focusing on stocks such as SCHOTT Pharma AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, and Fresenius SE & Co. KGaA. According to TipRanks, Vane has an average return of -1.6% and a 48.44% success rate on recommended stocks.

In addition to Jefferies, Fresenius Medical Care AG & Co. KGaA also received a Sell from Morgan Stanley’s Aisyah Noor in a report issued on February 26. However, on February 27, TipRanks – OpenAI reiterated a Hold rating on Fresenius Medical Care AG & Co. KGaA (LSE: 0H9X).

See the top stocks recommended by analysts >>

The company has a one-year high of €54.02 and a one-year low of €35.67. Currently, Fresenius Medical Care AG & Co. KGaA has an average volume of 939.1K.

Read More on GB:0H9X:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).